SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-18-006606
Filing Date
2018-08-07
Accepted
2018-08-07 16:27:27
Documents
58
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q ardx-20180630x10q.htm 10-Q 1769982
2 EX-10.1 ardx-20180630ex101bb8c88.htm EX-10.1 800638
3 EX-10.2 ardx-20180630ex102467e2d.htm EX-10.2 55832
4 EX-10.3 ardx-20180630ex1031a451a.htm EX-10.3 93631
5 EX-31.1 ardx-20180630ex311070287.htm EX-31.1 22329
6 EX-31.2 ardx-20180630ex312f4edf5.htm EX-31.2 22313
7 EX-32.1 ardx-20180630ex321c95a04.htm EX-32.1 16819
  Complete submission text file 0001558370-18-006606.txt   6913068

Data Files

Seq Description Document Type Size
8 EX-101.INS ardx-20180630.xml EX-101.INS 1360020
9 EX-101.SCH ardx-20180630.xsd EX-101.SCH 35504
10 EX-101.CAL ardx-20180630_cal.xml EX-101.CAL 48764
11 EX-101.DEF ardx-20180630_def.xml EX-101.DEF 118736
12 EX-101.LAB ardx-20180630_lab.xml EX-101.LAB 272392
13 EX-101.PRE ardx-20180630_pre.xml EX-101.PRE 223988
Mailing Address 34175 ARDENWOOD BLVD. FREMONT CA 94555
Business Address 34175 ARDENWOOD BLVD. FREMONT CA 94555 510-745-7047
ARDELYX, INC. (Filer) CIK: 0001437402 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36485 | Film No.: 18998479
SIC: 2834 Pharmaceutical Preparations